text_1: 32% of liver transplantation programs required patients to discontinue methadone treatment in 2001.
text_2: Policies requiring discontinuation of methadone in 32% of all programs contradict the evidence base for efficacy of long-term replacement therapies and potentially result in relapse of previously stable patients.